Clinical Trial Update: An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis [Phase 3]

View source ↗

Summary

Pfizer is conducting a Phase 3 extension study for the treatment of moderately to severely active ulcerative colitis; the trial is currently active but not recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Pfizer investigational product

Snippet

Sponsor: Pfizer | Conditions: Ulcerative Colitis | Phase 3 | Status: ACTIVE_NOT_RECRUITING